Presentation TCT Abstracts Posters 2019 Long-term Clinical Outcomes For All-comer Denovo Coronary Artery Lesions Treated With Paclitaxel-Coated Balloons Presenter: Nhung Nguyen October 08, 2019
Presentation TCT 2019 Paclitaxel-Coated Balloons for Coronary Intervention: Critical Review of Long-Term Trial Data in Light of the PAD Controversy — The DAEDALUS Collaboration Presenter: Robert Byrne September 28, 2019
Presentation TCT 2019 Sustained Limus Release-Designed Drug-Eluting Balloons: Is This the Solution for the Potential Increased Mortality With Paclitaxel Devices When Treating the SFA? Presenter: Thomas Zeller September 27, 2019
Presentation TCT 2019 Clinical Randomized Trial Evaluating Novel, Microcrystalline, and Biocompatible Polymer Paclitaxel-Coated Balloon for the Treatment of Femoro-Popliteal Occlusive Disease: 3-Year Clinical and Ambulatory Outcome Presenter: Piotr Buszman September 27, 2019
Presentation TCT 2019 Clinical Outcome at 6 Months Between Paclitaxel-Coated Balloon vs. Sirolimus-Coated Balloon in De Novo Coronary Lesions Presenter: Sandeep Basavarajaiah September 27, 2019
Presentation TCT 2019 Absence of Risk of Death After Coronary Paclitaxel-Coated Balloons: Systematic Review and Meta-Analysis of Randomized Trials Presenter: Bruno Scheller September 27, 2019
Presentation TCT 2019 Treating Challenging SFA Disease in the Era of Paclitaxel Uncertainty Presenter: Aravinda Nanjundappa September 27, 2019
Presentation TCT 2019 Emerging Safety Signals and FDA’s Medical Device Safety Action Plan: Responses to the Late Mortality Signal Presenter: Rebecca Ward September 26, 2019
Presentation TCT 2019 Potential Study Designs to Address the Mortality Safety Signal Presenter: Laura Mauri September 26, 2019
Presentation TCT 2019 Informed Consent and Impact on Clinical Practice: A Clinician’s Perspective and a Pathway Forward Presenter: Sahil Parikh September 26, 2019
Presentation TCT 2019 Drug-Eluting Technologies for SFA Disease: Industry’s Perspective and a Pathway Forward Presenter: Ian Meredith AM September 26, 2019
Presentation TCT 2019 Is Paclitaxel-Related Mortality From SFA Drug-Eluting Technologies Biologically Plausible? Presenter: Elazer Edelman September 26, 2019
Presentation TCT 2019 Paclitaxel-Coated Devices for SFA Disease: An Independent, Patient-Level Meta-Analysis and Other Emerging Data Presenter: Krishna Rocha-Singh September 26, 2019
Presentation TCT 2019 New Insights From Our Meta-Analysis of Paclitaxel-Coated Device Randomized Trials for SFA Disease (And the Response It Has Generated) Presenter: Konstantinos Katsanos September 26, 2019
Presentation TCT 2019 1-Year Late Lumen Loss With a Polymer-Coated Paclitaxel-Eluting Stent and a Polymer-Free Paclitaxel-Coated Stent for Femoropopliteal Disease: Study Results Presenter: Daizo Kawasaki September 26, 2019
Presentation TCT 2019 Mortality Risk Following Application of Paclitaxel-Coated Devices in Femoropopliteal Lesion: Results From the CAROOT Study Presenter: Yoshimitsu Soga September 26, 2019
Presentation TCT 2019 Safety of PTX Devices for PAD in Japan: Academic View Presenter: Masato Nakamura September 26, 2019
Presentation TCT 2019 Statistical Considerations: Competing Risk, Pooling Data, RCT vs. Observational Data Presenter: Roseann White September 26, 2019
Presentation TCT 2019 Moving From “Signal Detection” to “Signal Discernment”: An FDA View Presenter: Eleni Whatley September 26, 2019
Presentation TCT 2019 Current DCBs: Challenges of Paclitaxel and the Downsides of Coatings Presenter: Robert Byrne September 26, 2019